Fig. 2.
Fig. 2. Determination of CD95L expression on normal PBMC (before and after PHA/IL-2 activation) and in 2 cases of freshly isolated LGL leukemia (cases no. 4 and 11). The cells were fixed and permeabilized and then stained with anti-CD95L MoAb (C-20) followed by secondary antirabbit-FITC MoAb. The shaded area represents the level of fluorescence obtained with an isotype control MoAb, the unshaded area represents the level with CD95L MoAb.

Determination of CD95L expression on normal PBMC (before and after PHA/IL-2 activation) and in 2 cases of freshly isolated LGL leukemia (cases no. 4 and 11). The cells were fixed and permeabilized and then stained with anti-CD95L MoAb (C-20) followed by secondary antirabbit-FITC MoAb. The shaded area represents the level of fluorescence obtained with an isotype control MoAb, the unshaded area represents the level with CD95L MoAb.

Close Modal

or Create an Account

Close Modal
Close Modal